Research ArticleArticle
Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus
Lidan Zhao, Dong Xu, Lin Qiao and Xuan Zhang
The Journal of Rheumatology May 2016, jrheum.150829; DOI: https://doi.org/10.3899/jrheum.150829
Lidan Zhao
From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. L. Zhao*, MD, Attending Physician, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; D. Xu*, MD, Associate Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; L. Qiao, MD, Postgraduate, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; X. Zhang, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. * L. Zhao and D. Xu contributed equally to this report. Address correspondence to Dr. Z. Xuan, Shuai Fu Yuan 1, Dongcheng District, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication February 18, 2016.
Dong Xu
From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. L. Zhao*, MD, Attending Physician, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; D. Xu*, MD, Associate Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; L. Qiao, MD, Postgraduate, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; X. Zhang, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. * L. Zhao and D. Xu contributed equally to this report. Address correspondence to Dr. Z. Xuan, Shuai Fu Yuan 1, Dongcheng District, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication February 18, 2016.
Lin Qiao
From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. L. Zhao*, MD, Attending Physician, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; D. Xu*, MD, Associate Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; L. Qiao, MD, Postgraduate, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; X. Zhang, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. * L. Zhao and D. Xu contributed equally to this report. Address correspondence to Dr. Z. Xuan, Shuai Fu Yuan 1, Dongcheng District, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication February 18, 2016.
Xuan Zhang
From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. L. Zhao*, MD, Attending Physician, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; D. Xu*, MD, Associate Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; L. Qiao, MD, Postgraduate, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; X. Zhang, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. * L. Zhao and D. Xu contributed equally to this report. Address correspondence to Dr. Z. Xuan, Shuai Fu Yuan 1, Dongcheng District, Beijing, China, 100730. E-mail: zxpumch2003@sina.com. Accepted for publication February 18, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus
Lidan Zhao, Dong Xu, Lin Qiao, Xuan Zhang
The Journal of Rheumatology May 2016, jrheum.150829; DOI: 10.3899/jrheum.150829